McKessonMEX:MCK 75 Buyback Yield % is 5.06 as of Jul. 06, 2026, which is 7% below its 10-year median of 5.45. GuruFocus rates MEX:MCK with a GF Score™ of 75/100 and a GF Value™ of MXN14,259.08 (Fairly Valued). The stock has 2 warning signs investors should review. Among 39 Medical Distribution companies, McKesson ranks better than 87.18% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for McKesson's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MCK vs CAH, COR, HSIC: Buyback Yield % Comparison
For the Medical Distribution subindustry, McKesson's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McKesson Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, McKesson's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where McKesson's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
McKesson (MEX:MCK) has a Buyback Yield % of 5.06 as of Jul. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on McKesson and its competitors. This is near median its historical median of 5.45. Over the past decade, McKesson's Buyback Yield % has ranged from 1.46 to 9.82. According to the industry distribution chart, McKesson ranks #5 out of 39 companies in the Medical Distribution industry, placing it in the top 12.8%.
Is McKesson's Buyback Yield % too high?
McKesson's current Buyback Yield % of 5.06 is near median its 10-year median of 5.45. Over the past 10 years, this metric has ranged from a low of 1.46 to a high of 9.82. The Medical Distribution industry median Buyback Yield % is 0.05. McKesson's value of 5.06 is 10020% above this industry median. Based on the distribution chart, McKesson ranks #5 out of 39 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, McKesson has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's Buyback Yield % compare to CAH and COR?
According to the Medical Distribution industry distribution chart, McKesson ranks #5 out of 39 companies for Buyback Yield %. This places McKesson in the top 13% of its industry — outperforming the majority of peers. The industry median Buyback Yield % is 0.05. McKesson's value of 5.06 is 10020% above this benchmark. Historically, McKesson's own Buyback Yield % has ranged from 1.46 to 9.82 over the past decade. While the company's 10-year median is 5.45 vs. the industry median of 0.05, McKesson has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.05, based on 39 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. McKesson's current Buyback Yield % of 5.06 is 10020% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on McKesson and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. McKesson's current Buyback Yield % is 5.06, which is near median its own 10-year median of 5.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (MEX:MCK) is currently considered Fairly Valued. The stock's GF Value™ is MXN14,259.08, compared to a current price of MXN13,691.02 — trading 4% below its estimated fair value. The current Buyback Yield % is 5.06, which is near median its 10-year median of 5.45 and 10020% above the Medical Distribution industry median of 0.05. McKesson's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For McKesson (MEX:MCK), the current Buyback Yield % is 5.06 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is McKesson (MEX:MCK) Overvalued in 2026?
Based on GuruFocus' analysis, McKesson stock appears to be undervalued.
The current stock price of MXN13,691.02 is trading 4% below its estimated GF Value™ of MXN14,259.08.
GuruFocus considers McKesson to be Fairly Valued.
Key valuation signals for MEX:MCK:
Buyback Yield %: 5.06 (near median its 10-year median of 5.45)
GF Value™: MXN14,259.08 vs. price of MXN13,691.02 (4% below fair value)
Industry Position: 10020% above the Medical Distribution median (#5 of 39)
No single metric tells the full story. See the MEX:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
75GF Score
Get the complete analysis for MEX:MCK
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MCK has been successfully added to your 
